RAB38 promotes bladder cancer growth by promoting cell proliferation and motility.
Da-Wei TianSheng-Lai LiuLi-Ming JiangZhou-Liang WuJie GaoHai-Long HuChang-Li WuPublished in: World journal of urology (2018)
In conclusion, this study provides significant evidence that RAB38 promotes the development of bladder cancer and provides a novel therapeutic target of bladder cancer.